...
首页> 外文期刊>Angiogenesis >Silencing of S100A4, a metastasis-associated protein, in endothelial cells inhibits tumor angiogenesis and growth
【24h】

Silencing of S100A4, a metastasis-associated protein, in endothelial cells inhibits tumor angiogenesis and growth

机译:转移相关蛋白S100A4的沉默在内皮细胞中抑制肿瘤血管生成和生长。

获取原文
获取原文并翻译 | 示例

摘要

Endothelial cells express S100A4, a metastasis-associated protein, but its role in angiogenesis remains to be elucidated. Here we show that knockdown of S100A4 in mouse endothelial MSS31 cells by murine specific small interference RNA (mS100A4 siRNA) markedly suppressed capillary-like tube formation in vitro, in early stage after the treatment, along with down- and up-regulation of some of the pro-angiogenic and anti-angiogenic gene expression, respectively. Of particular note is that intra-tumor administration of the mS100A4 siRNA in a human prostate cancer xenograft significantly reduced tumor vascularity and resulted in the inhibition of tumor growth. These findings show that S100A4 in endothelial cells is involved in tube formation, and suggest its potential as a molecular target for inhibiting tumor angiogenesis, which warrants further development of endothelial S100A4-based strategies for cancer treatment.
机译:内皮细胞表达S100A4,一种与转移相关的蛋白,但其在血管生成中的作用尚待阐明。在这里,我们显示小鼠特异性小干扰RNA(mS100A4 siRNA)在小鼠内皮MSS31细胞中敲低S100A4在体外,治疗后的早期显着抑制了毛细血管样管的形成,以及某些药物的上下调节分别促血管生成和抗血管生成基因的表达。特别值得注意的是,在人前列腺癌异种移植物中肿瘤内给予mS100A4 siRNA显着降低了肿瘤血管,并导致了肿瘤生长的抑制。这些发现表明,内皮细胞中的S100A4参与了管的形成,并暗示了其作为抑制肿瘤血管生成的分子靶标的潜力,这保证了基于内皮S100A4的癌症治疗策略的进一步发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号